Painless Blood Glucose Monitoring Device Market Research： the market size is projected to grow from USD xx million in 2023 to USD xx million by 2030

Painless Blood Glucose Monitoring Device could measure your glucose without hurt your finger. Painless Blood Glucose Monitoring Device refers to the measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from the disease) without drawing blood, puncturing the skin, or causing pain or trauma.

The painless blood glucose monitoring device market is driven by the increasing prevalence of diabetes and the rising demand for non-invasive and minimally invasive glucose monitoring solutions. According to the International Diabetes Federation (IDF), over 537 million adults were living with diabetes in 2021, a number projected to reach 783 million by 2045. Traditional fingerstick glucose testing is often painful and inconvenient, leading to poor adherence among patients. As a result, advancements in continuous glucose monitoring (CGM) technologies, such as optical, transdermal, and implantable sensors, are gaining traction. Companies like Abbott, Dexcom, Senseonics, and GlucoTrack are investing in painless monitoring solutions, aiming to improve patient comfort and long-term diabetes management outcomes.

Despite strong market growth, challenges include high costs, regulatory hurdles, and technological limitations. Many non-invasive glucose monitoring technologies, such as near-infrared spectroscopy and electromagnetic sensing, face accuracy issues compared to traditional blood-based methods. Additionally, regulatory approvals from bodies like the FDA and CE require extensive clinical validation, slowing market entry. The high cost of painless CGM devices also limits adoption in developing markets, where affordability remains a key concern. Overcoming these challenges requires continued technological innovation, cost reduction, and regulatory support to ensure painless glucose monitoring becomes widely accessible.

The painless blood glucose monitoring device market is witnessing a shift towards non-invasive and minimally invasive technologies, driven by advancements in biosensors, optical sensing, and artificial intelligence (AI)-powered glucose tracking. Companies are increasingly investing in wearable and implantable CGM (Continuous Glucose Monitoring) systems, with innovations such as Eversense’s long-term implantable sensors, Abbott’s FreeStyle Libre, and Dexcom G7 gaining popularity. Additionally, startups and research institutions are exploring alternative glucose measurement methods using sweat, saliva, and tears, aiming to eliminate the need for fingerstick calibration entirely. The integration of AI-driven predictive analytics is also a growing trend, helping diabetes patients better manage their blood sugar levels by forecasting trends and recommending lifestyle adjustments.

Another significant trend is the expanding accessibility and affordability of CGM devices, particularly in emerging markets. While early-generation CGM systems were costly and primarily available in developed nations, competition among key players and technological advancements are gradually reducing costs. Governments and healthcare organizations are also supporting reimbursement programs for painless glucose monitoring devices, further driving adoption. The integration of CGM with insulin pumps is another emerging trend, creating a closed-loop diabetes management system, sometimes referred to as the artificial pancreas. As regulatory approvals increase and production costs decrease, the market is expected to expand rapidly, making painless blood glucose monitoring more accessible to a larger diabetic population worldwide.

According to the new market research report "Painless Blood Glucose Monitoring Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031", published by QYResearch, the global Painless Blood Glucose Monitoring Device market size is projected to grow from USD xx million in 2023 to USD xx million by 2030, at a CAGR of xx% during the forecast period.

• Global Painless Blood Glucose Monitoring Device MarketSize(US$ Million), 2020-2031

Source: QYResearch, "Painless Blood Glucose Monitoring Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

• Global Painless Blood Glucose Monitoring Device Top12Players Ranking and Market Share (Ranking is based on the revenue of 2024, continually updated)

Source: QYResearch, "Painless Blood Glucose Monitoring Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Painless Blood Glucose Monitoring Device include Abbott, DexCom, Medtronic, SIBIONICS, POCTech, etc. In 2024, the global top five players had a share approximately 11.0% in terms of revenue.

About The Authors

Zhang Xiao - Lead Author

Email: zhangxiao@qyresearch.com

Zhang Xiao is a market senior analyst specializing in medical device, pharma, Lab consumable. Zhang  Xiao has 8 years’ experience in medical device and  pharma market analysis, and focuses on medical device and consumables (imaging equipment, medical consumables, wearable medical equipment, medical robots, home care equipment, dental equipment, implant equipment, operating room equipment, in vitro diagnostics, etc.) and drugs (API, finished drugs, patented drugs, blood products , vaccines, etc.) . She is engaged in the development of technology and market reports and is also involved in custom projects.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp